Liver X Receptors in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential

Liver X receptors (LXRs), comprising LXRα and LXRβ, are oxysterol-responsive nuclear receptors that regulate cholesterol homeostasis and inflammatory signaling. In the central nervous system (CNS), LXR activity influences amyloid-β metabolism, glial responses, synaptic integrity, myelination, and blood–brain barrier function. This narrative review synthesizes shared and disease-specific mechanisms across neurodegenerative and demyelinating disorders, distinguishing established experimental effects from proposed pathways. We compare representative LXR modulators by receptor and transcriptional selectivity, CNS exposure, efficacy, and safety. Particular attention is given to hepatic lipogenesis caused by systemic LXRα activation and to LXRβ-selective or function-selective ligands, brain-targeted delivery, combination strategies, and biomarker-guided patient stratification. Although preclinical findings support therapeutic potential, clinical efficacy remains unproven. Priorities include cell-type-specific causal validation, quantitative CNS target engagement, and long-term safety assessment.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2026-11-12
DOI
https://doi.org/10.3390/biom16111654
Primary Topic
Cholesterol and Lipid Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Liver X Receptors in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential

Peng Zeng, 刘文华, Zhixian Mo, 李翰城 et al.
Biomolecules
Cholesterol and Lipid Metabolism
article

Liver X Receptors in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential

Peng Zeng, 刘文华, Zhixian Mo, 李翰城, Jinwei Gan, Chaohua Luo, Hongwu Wang
article en

Abstract

Liver X receptors (LXRs), comprising LXRα and LXRβ, are oxysterol-responsive nuclear receptors that regulate cholesterol homeostasis and inflammatory signaling. In the central nervous system (CNS), LXR activity influences amyloid-β metabolism, glial responses, synaptic integrity, myelination, and blood–brain barrier function. This narrative review synthesizes shared and disease-specific mechanisms across neurodegenerative and demyelinating disorders, distinguishing established experimental effects from proposed pathways. We compare representative LXR modulators by receptor and transcriptional selectivity, CNS exposure, efficacy, and safety. Particular attention is given to hepatic lipogenesis caused by systemic LXRα activation and to LXRβ-selective or function-selective ligands, brain-targeted delivery, combination strategies, and biomarker-guided patient stratification. Although preclinical findings support therapeutic potential, clinical efficacy remains unproven. Priorities include cell-type-specific causal validation, quantitative CNS target engagement, and long-term safety assessment.

BiomoleculesVol. 16(11)
Zhaoqing University (CN), Southern Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Cholesterol and Lipid Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon